{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:13:30Z","timestamp":1783538010202,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Greenwich Biosciences, Inc."}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.yebeh.2020.107494","type":"journal-article","created":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T22:57:33Z","timestamp":1601852253000},"page":"107494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Economic burden associated with tuberous sclerosis complex in patients with epilepsy"],"prefix":"10.1016","volume":"112","author":[{"given":"Keith A.","family":"Betts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Stockl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Hollenack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2020.107494_bb0005","author":"US National Library of Medicine (Genetics Home Reference)"},{"issue":"13","key":"10.1016\/j.yebeh.2020.107494_bb0010","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2020.107494_bb0015","author":"National Organization for Rare Diseases"},{"issue":"7","key":"10.1016\/j.yebeh.2020.107494_bb0020","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"51","author":"Chu-Shore","year":"2010","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.yebeh.2020.107494_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155331","article-title":"Women with TSC: relationship between clinical, lung function and radiological features in a genotyped population investigated for lymphangioleiomyomatosis","volume":"11","author":"Di Marco","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2020.107494_bb0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s41687-018-0055-4","article-title":"Burden of renal angiomyolipomas associated with tuberous sclerosis complex: results of a patient and caregiver survey","volume":"2","author":"Rentz","year":"2018","journal-title":"J Patient Rep Outcomes"},{"issue":"10","key":"10.1016\/j.yebeh.2020.107494_bb0035","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","article-title":"Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors","volume":"70","author":"Rakowski","year":"2006","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.yebeh.2020.107494_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001493","article-title":"Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International Tuberous Sclerosis Consensus Group","volume":"3","author":"Hinton","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107494_bb0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13023-016-0553-5","article-title":"TuberOus SClerosis registry to increase disease Awareness (TOSCA) \u2014 baseline data on 2093 patients","volume":"12","author":"Kingswood","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"10.1016\/j.yebeh.2020.107494_bb0050","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/adc.2011.211995","article-title":"The Tuberous Sclerosis 2000 Study: presentation, initial assessments and implications for diagnosis and management","volume":"96","author":"Yates","year":"2011","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107494_bb0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13023-018-0901-8","article-title":"TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study","volume":"13","author":"de Vries","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.yebeh.2020.107494_bb0060","first-page":"2021","article-title":"Optimal management of seizures associated with tuberous sclerosis complex: current and emerging options","volume":"10","author":"Wang","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"12","key":"10.1016\/j.yebeh.2020.107494_bb0065","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.7150\/jca.14747","article-title":"Is mTOR inhibitor good enough for treatment all tumors in TSC patients?","volume":"7","author":"Habib","year":"2016","journal-title":"J Cancer"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107494_bb0070","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/157015912804499537","article-title":"mTOR inhibitors in tuberous sclerosis complex","volume":"10","author":"Curatolo","year":"2012","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107494_bb0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2020.107494_bb0080","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jns.2018.06.011","article-title":"Epilepsy treatment patterns among patients with tuberous sclerosis complex","volume":"391","author":"Song","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2020.107494_bb0085","author":"Mattel Children's Hospital UCLA"},{"key":"10.1016\/j.yebeh.2020.107494_bb0090","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3389\/fneur.2019.01144","article-title":"Treatment patterns and use of resources in patients with tuberous sclerosis complex: insights from the TOSCA registry","volume":"10","author":"Marques","year":"2019","journal-title":"Front Neurol"},{"issue":"8","key":"10.1016\/j.yebeh.2020.107494_bb0095","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/epi.13050","article-title":"Epilepsy in children with tuberous sclerosis complex: chance of remission and response to antiepileptic drugs","volume":"56","author":"Overwater","year":"2015","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.yebeh.2020.107494_bb0100","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1528-1167.2007.01117.x","article-title":"Epilepsy surgery in tuberous sclerosis: a systematic review","volume":"48","author":"Jansen","year":"2007","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107494_bb0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13023-019-1258-3","article-title":"A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC)","volume":"15","author":"Zollner","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107494_bb0110","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pediatrneurol.2014.11.013","article-title":"Tuberous sclerosis complex: a survey of health care resource use and health burden","volume":"52","author":"Rentz","year":"2015","journal-title":"Pediatr Neurol"},{"issue":"8","key":"10.1016\/j.yebeh.2020.107494_bb0115","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1185\/03007995.2011.586687","article-title":"Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review","volume":"27","author":"Hallett","year":"2011","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107494_bb0120","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/epi4.12365","article-title":"Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex","volume":"4","author":"Vergeer","year":"2019","journal-title":"Epilepsia Open"},{"issue":"10","key":"10.1016\/j.yebeh.2020.107494_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015236","article-title":"Understanding the health economic burden of patients with tuberous sclerosis complex (TSC) with epilepsy: a retrospective cohort study in the UK Clinical Practice Research Datalink (CPRD)","volume":"7","author":"Shepherd","year":"2017","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.yebeh.2020.107494_bb0130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/13696998.2016.1199432","article-title":"The economic burden of tuberous sclerosis complex in the UK: a retrospective cohort study in the Clinical Practice Research Datalink","volume":"19","author":"Kingswood","year":"2016","journal-title":"J Med Econ"},{"issue":"10","key":"10.1016\/j.yebeh.2020.107494_bb0135","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1080\/13696998.2018.1487447","article-title":"Economic burden, work, and school productivity in individuals with tuberous sclerosis and their families","volume":"21","author":"Skalicky","year":"2018","journal-title":"J Med Econ"},{"key":"10.1016\/j.yebeh.2020.107494_bb0140","author":"Symphony Health Solutions"},{"key":"10.1016\/j.yebeh.2020.107494_bb0145","author":"World Health Organization"},{"issue":"5","key":"10.1016\/j.yebeh.2020.107494_bb0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"11","key":"10.1016\/j.yebeh.2020.107494_bb0155","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107494_bb0160","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0883073812448437","article-title":"Resource utilization in children with tuberous sclerosis complex and associated seizures: a retrospective chart review study","volume":"28","author":"Lennert","year":"2013","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2020.107494_bb0165","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.seizure.2017.10.005","article-title":"Epilepsy in tuberous sclerosis patients in Sweden \u2014 healthcare utilization, treatment, morbidity, and mortality using national register data","volume":"53","author":"Welin","year":"2017","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107494_bb0170","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2020.107494_bb0175","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/088307389901400610","article-title":"Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association","volume":"14","author":"Roach","year":"1999","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2020.107494_bb0180","author":"US Food and Drug Administration"},{"key":"10.1016\/j.yebeh.2020.107494_bb0185","author":"US Food and Drug Administration"},{"issue":"10","key":"10.1016\/j.yebeh.2020.107494_bb0190","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1111\/epi.13857","article-title":"Health care resource utilization before and after perampanel initiation among patients with epilepsy in the United States","volume":"58","author":"Faught","year":"2017","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020306740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020306740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:39:13Z","timestamp":1761503953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020306740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":38,"alternative-id":["S1525505020306740"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107494","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic burden associated with tuberous sclerosis complex in patients with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107494","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107494"}}